VerifyRecall
Alerts
RECALL RECORD — CLASS IRecall completedH-0337-2025/FDA enforcement
Llk Trading INC·Food·Jun 16, 2025

Needle Mushrooms, Product of China, 200 Gram Packages, Plastic Clear Packaging on Top with Blue…

What you need to know

Class I

  • What happened

    Product tested positive for L. monocytogenes.

  • Health risk

    The product has a reasonable probability of causing serious adverse health consequences or death. A safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

  • Action required

    Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice.

Recall completed · classified by the FDANYMore food

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA FOOD

Brand nameLlk Trading INC
Recalling firmLlk Trading INCLinden, NJ, United States
UPC / barcodesNo UPC listed in the FDA enforcement record.
Lot / date codesNo lot code listed. Follow the recall notice and check the packaging.
Distribution area
NY

The firms recalled product was distributed to the following State: NY

United States

Quantity affected80 Cases
Recall initiationFDA report date: July 30, 2025
FDA recall numberH-0337-2025

Beyond the headline

The recall, in context

Llk Trading INC initiated this food recall on June 16, 2025. The FDA enforcement report states: Product tested positive for L. monocytogenes. The FDA report lists distribution as: The firms recalled product was distributed to the following State: NY.

The FDA enforcement report describes the reason as: Product tested positive for L. monocytogenes.

Needle Mushrooms, Product of China, 200 Gram Packages, Plastic Clear Packaging on Top with Blue… was made or distributed by Llk Trading INC in Linden, NJ, United States. This page reflects FDA report H-0337-2025, dated July 30, 2025.

Why this is a Class I recall

Class I means the product has a reasonable probability of causing serious adverse health consequences or death. In this recall, a safety issue that does not fit the standard pathogen, allergen, chemical or quality categories.

FDA definition

The product has a reasonable probability of causing serious adverse health consequences or death.

What to do now

  1. 1

    Stop using it

    Do not eat, drink or take the affected product.

  2. 2

    Check the codes

    Compare the lot and date codes against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Listeria monocytogenes

Symptoms to watch for

Fever, muscle aches, nausea and diarrhea may occur. Severe infection can cause headache, stiff neck, confusion, loss of balance or convulsions.

When symptoms may appear

Symptoms can begin within a few days, but can take up to several weeks to appear.

Higher-risk groups

Pregnant people, newborns, adults over 65 and immunocompromised people are at the highest risk of severe illness.

What to do now

  1. 1Stop using or eating the affected product and keep it away from children and pets.
  2. 2Match the product against the UPC and lot/date codes on this page, then dispose of it safely or return it to the retailer.
  3. 3If you have already been exposed and develop severe or worsening symptoms, seek medical advice promptly.

General guidance based on CDC and FDA consumer information.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the Needle Mushrooms, Product of China, 200 Gram Packages, Plastic Clear Packaging on Top with Blue… recall?

Llk Trading INC recalled Needle Mushrooms, Product of China, 200 Gram Packages, Plastic Clear Packaging on Top with Blue… in an FDA Class I enforcement action reported as H-0337-2025. Product tested positive for L. monocytogenes.

What should I do if I bought this product?

Check the identifying codes below and stop using the product. Return it to the retailer for a refund or dispose of it safely, following the recall notice. Stop using or eating the affected product and keep it away from children and pets. Match the product against the UPC and lot/date codes on this page, then dispose of it safely or return it to the retailer. If you have already been exposed and develop severe or worsening symptoms, seek medical advice promptly.

Is the Llk Trading INC recall still active?

The FDA lists this recall as recall completed. It remains relevant if you still have the affected product or need to identify a historical recall.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record H-0337-2025. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by Llk Trading INC

View brand
Class I·

Llk Trading INC

Sss Brand and K-fresh Branded Enoki Mushrooms Packaged in Clear Plastic 200g Container

Xin Ao International Group Corp, 601 E. Linden Ave Linden NJ 07036is initiating a recall of Enoki Mushroom, 200g, Plastic Bag, 25 bags per case because the product may be…

INFood

Related alerts

Recent Other safety concern recalls

All alerts
Class II·

Sempio Food Services, INC

Sempio Yellow Peach

Elevated level of lead in canned peaches

INFood
Class II·

Stewart's Shops Corp.

Stewarts Shops Vanilla Heavenly Medley 1/2 Gallon (1.89 L)

Foreign object: May contain pieces of metal

NY, VT, NHFood

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.